Civic Intelligence

International Partnership for Microbicides Inc

990 • Fiscal year 2021 • EIN 01-0741733

Jan 01, 2021 to Dec 31, 2021 • Filed on Nov 14, 2022

Organization ProfileWWW.IPMGLOBAL.ORG

View Organization Page

8405 Colesville Road 600Silver Spring, MD 20910

(301) 608-2221

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

60th percentile

0.27x

Higher debt load relative to assets than 60% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Liabilities / Revenue

50th percentile

0.22x

Higher debt load relative to revenue than 50% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Net Margin

26th percentile

1.6%

Higher net margin than 26% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Top Officer Pay

93rd percentile

$566,610

Higher top officer pay than 93% of similar nonprofits.

Top officer pay equals 2.8% of source-year revenue.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Source year 2021

Asset Growth

2nd percentile

-31%

Faster asset growth than 2% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2020 to 2021

Revenue Growth

30th percentile

0.3%

Faster revenue growth than 30% of similar nonprofits.

2021 filings • 501(c)3 • $10M-$25M nonprofits • Annualized from 2020 to 2021

Balance Sheet
Liabilities / Assets60th percentile

Assets

Down

$16,214,079

Down $7,256,614 (-31%) from 2020

Net Assets

Up

$11,828,967

Up $274,598 (+2.4%) from 2020

Liabilities

Down

$4,385,112

Down $7,531,212 (-63%) from 2020

Revenue And Expenses
Liabilities / Revenue50th percentileNet Margin26th percentile

Revenue

Up

$20,220,623

Up $55,839 (+0.3%) from 2020

Expenses

Down

$19,901,457

Down $850,697 (-4.1%) from 2020

Net Income

Up

$319,166

Up $906,536 (+154%) from 2020

Historical Trend

Balance Sheet Trend

Asset Growth2nd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $81,520,037Liabilities 2010: $58,213,017Net Assets 2010: $23,307,0202010Assets 2011: $52,600,905Liabilities 2011: $31,502,185Net Assets 2011: $21,098,7202011Assets 2012: $41,958,199Liabilities 2012: $22,695,453Net Assets 2012: $19,262,7462012Assets 2013: $40,537,408Liabilities 2013: $23,421,275Net Assets 2013: $17,116,1332013Assets 2014: $28,873,020Liabilities 2014: $14,087,446Net Assets 2014: $14,785,5742014Assets 2015: $23,222,913Liabilities 2015: $10,179,304Net Assets 2015: $13,043,6092015Assets 2016: $20,060,195Liabilities 2016: $5,525,129Net Assets 2016: $14,535,0662016Assets 2017: $23,049,272Liabilities 2017: $9,788,866Net Assets 2017: $13,260,4062017Assets 2018: $24,838,200Liabilities 2018: $12,803,774Net Assets 2018: $12,034,4262018Assets 2019: $28,113,782Liabilities 2019: $15,676,294Net Assets 2019: $12,437,4882019Assets 2020: $23,470,693Liabilities 2020: $11,916,324Net Assets 2020: $11,554,3692020Assets 2021: $16,214,079Liabilities 2021: $4,385,112Net Assets 2021: $11,828,9672021Assets 2022: $0Liabilities 2022: $0Net Assets 2022: $02022

Highlighted filing

2021

Assets$16,214,079
Liabilities$4,385,112
Net Assets$11,828,967
Open 2021 Filing

Operations Trend

Revenue Growth30th percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$60M$40M$20M$0-$20MExpenses 2010: $56,341,7012010Expenses 2011: $37,733,2382011Revenue 2012: $31,674,981Expenses 2012: $31,029,986Net Income 2012: $644,9952012Revenue 2013: $32,787,591Expenses 2013: $33,447,172Net Income 2013: -$659,5812013Revenue 2014: $31,552,023Expenses 2014: $32,244,291Net Income 2014: -$692,2682014Revenue 2015: $33,000,728Expenses 2015: $33,224,496Net Income 2015: -$223,7682015Revenue 2016: $35,971,802Expenses 2016: $33,779,041Net Income 2016: $2,192,7612016Revenue 2017: $35,724,324Expenses 2017: $36,807,047Net Income 2017: -$1,082,7232017Revenue 2018: $25,206,212Expenses 2018: $26,337,178Net Income 2018: -$1,130,9662018Revenue 2019: $25,249,274Expenses 2019: $24,773,576Net Income 2019: $475,6982019Revenue 2020: $20,164,784Expenses 2020: $20,752,154Net Income 2020: -$587,3702020Revenue 2021: $20,220,623Expenses 2021: $19,901,457Net Income 2021: $319,1662021Revenue 2022: $9,961,492Expenses 2022: $12,803,344Net Income 2022: -$2,841,8522022

Highlighted filing

2021

Revenue$20,220,623
Expenses$19,901,457
Net Income$319,166
Open 2021 Filing
Jump To
Filing Snapshot
Filing Period
Jan 1, 2021 to Dec 31, 2021
Signed
Nov 14, 2022
Return Version
2021v4.2
Gross Receipts
$20,220,623
Mission and Program Overview

Mission

The international partnership for microbicides, inc. (ipm) was established in 2002 to accelerate the development and accessibility of microbicides to prevent the transmission of hiv. Its goal is to improve the efficiency to all efforts to deliver a safe and effective microbicide for women in developing countries as soon as possible.

To develop hiv prevention products and other sexual and reproductive health technologies for women, and to make them available and accessible where they are urgently needed.

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$15,149,778$11,255,745▼ $3,894,033
Pledges and Grants Receivable$5,388,424$1,906,142▼ $3,482,282
Land, Buildings, and Equipment, Net$1,600,635$923,074▼ $677,561
Inventories for Sale or Use$458,683$721,130▲ $262,447
Accounts Receivable$115,729$531,162▲ $415,433
Prepaid Expenses and Deferred Charges$464,624$513,564▲ $48,940
Savings and Temporary Cash Investments$292,820$363,262▲ $70,442
Total Assets$23,470,693$16,214,079▼ $7,256,614
Liabilities
Accounts Payable and Accrued Expenses$3,127,333$2,854,197▼ $273,136
Deferred Revenue$8,268,635$1,126,246▼ $7,142,389
Other Liabilities$520,356$404,669▼ $115,687
Total Liabilities$11,916,324$4,385,112▼ $7,531,212
Net Assets / Fund Balance
Net Assets Without Donor Restrictions$11,554,369$11,828,967▲ $274,598
Total Net Assets Fund Balance$11,554,369$11,828,967▲ $274,598
Total Liabilities and Net Assets / Fund Balance$23,470,693$16,214,079▼ $7,256,614

Asset Categories

AssetBook ValueDepreciationBasis
Equipment$568,726$4,573,149$5,141,875
Other Land Buildings$32,486$980,338$1,012,824
Leasehold Improvements$321,862$506,316$828,178
Compensation and Service Providers
Top Officer Pay93rd percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Zeda RosenburgFounder & CEOPT$491,637$74,973$566,610
Brid DevlinEvp, Product DevelopmentFT$387,449$84,343$471,792
Patricia Mayer-brennanEvp, Regulatory AffairsFT$369,511$81,546$451,057
Kathleen FlynnEvp, Chief Financial OfficerFT$324,577$58,931$383,508
Liza FolsteinVP, Human ResourcesFT$256,123$69,809$325,932
Jeremy NuttallVP, Preclinical SciencesFT$257,833$66,309$324,142
Anita GargVP, Strat. Planning & Prog. Mgmt.FT$246,569$63,493$310,062
Patrick SpenceSr. Dir, Chemistry & AnalyticalFT$224,840$72,357$297,197
Bindi DangiSr. Dir, Project Mgmt & OpsFT$215,206$64,875$280,081
Michael GoldrichPresident & COO -until 03/2021FT$129,902$14,522$144,424

Board Members and Trustees

NameTitle
Alex CoutinhoDirector
Anja GiphartDirector
Florence HounDirector
Georgina CaswellDirector
Hilde Frafjord JohnsonDirector
Lillian MworekoDirector
Mark MitchnickDirector
Maureen LubaDirector
Pamela BarnesDirector
Tlaleng MofokengDirector
William CollierDirector

Highest Paid Contractors

ContractorServicesLocationCompensation
Qpharma AbManufacturing1050 CINDY LANE, Carpinteria, CA 93013, Sw$3,338,990
Ajinomoto Omnichem NvManufacturing11921 ROCKVILLE PIKE STE 210, Rockville, MD 20852, Be$2,296,963
Nusil Technology LLCManufacturing222 W LAS COLINAS BLVD STE 900N, Allen, TX 75039$384,905
Osibeyond LLCIt Services-$356,337
Celanese Canada UlcClinical Trial & Regulatory Sup. Fee-$295,771
Revenue and Support

Revenue Composition

Contributions and Grants
$20,007,666
Program Service Revenue
$0
Investment Income
$23,382
Other Revenue
$189,575
All Other Contributions
$622,301
Change in Net Assets
$319,166

Audited Revenue Reconciliation

Revenue per Audited Statements
$20,220,622
Revenue Not Reported on Financial Statements
$0
Revenue Not Reported on Form 990
$3,066,630
Total Revenue per Audited Statements
$23,287,252
Total Revenue per Form 990
$20,220,622
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$11,333,754
Salaries, Compensation, and Employee Benefits$8,567,703
Total Fundraising Expense$229,891
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$2,429,350$1,257,613$60,260$3,747,223
Current Officers, Directors, Trustees, and Key Employees$2,178,717$867,932$34,730$3,081,379
Office Expenses$1,319,343$89,728-$1,409,071
Other Employee Benefits$469,508$233,798$10,450$713,756
Depreciation Depletion$513,021$115,443-$628,464
Pension Plan Contributions$401,011$191,468$8,944$601,423
Payroll Taxes$291,033$126,611$6,278$423,922
Fees for Services Legal$243,747$43,837$446$288,030
Occupancy$237,052$21,736-$258,788
Insurance$184,784$73,528-$258,312
Fees for Services Accounting-$111,596-$111,596
Other Expenses$3,578$41,132$108,783$44,710
Conferences and Meetings$15,414$10,818-$26,232
Travel$1,977--$1,977
All Other Expenses-$1,930-$1,930
Total Functional Expenses$16,054,155$3,617,411$229,891$19,901,457

Audited Expense Reconciliation

Line ItemAmount
Total Expenses per Audited Statements$23,085,171
Expenses per Audited Statements$19,901,457
Total Expenses per Form 990$19,901,457
Expenses Not Reported on Form 990$3,183,714
Expenses Not Reported on Financial Statements$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Debt and Bond Financing

Other Reported Liabilities

LiabilityAmount
Deferred Rent Liability$404,669
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
Yes
Business relationship with 35% controlled entity
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Draft version is made available electronically to the finance committee before submission to the irs.”

Form 990, Part VI, Section B, Line 12C

“Employees are required to complete a confidentiality agreement with the organization annually. The employee discloses any areas of potential conflict of interest and agrees to notify the appropriate individuals of any potential occurrences.”

Form 990, Part VI, Section B, Line 15

“The salary of the ceo is determined by referencing industry data to identify compensation level based on responsibilities, size of organization, and funding levels. Once the data is accumulated, the information is then presented to the finance chairperson and committee for review and approval of the board of directors. Upon approval, the approved salary is sent to the hr department by a member of the board of directors and/or coo for implementation. All chief level salaries are subject to the same procedures as the ceo salary review process. Compensation level recommendations are presented to the finance chairperson and committee for review and approval of the board of directors. Once the compensation levels have been approved, a member of the board of directors and/or ceo and/or coo submits these approvals to hr for implementation.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are made available to the public upon request. The financial statements are also part of the organization's annual report which is distributed to its donors and available to the public upon request.”

Filing and Contact Details

Filer

Filer Name
International Partnership for
EIN
01-0741733
Phone
3016082221
Address
8405 COLESVILLE ROAD 600, SILVER SPRING, MD 20910

Signing Officer

Name
Kathleen Flynn
Title
CFO
Phone
3016082221
Signed
2022-11-14
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Kathleen Flynn
Formed
2002
Legal Domicile
Nc
Voting Board Members
12
Independent Board Members
12
Employees
35
Volunteers
13

Preparer

Firm
Marcum Llp
Address
1899 L STREET NW 850, WASHINGTON, DC 20036
Preparer
Aaron M Fox
Phone
2028225000
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

“Foreign currency loss -69,396.”

FORM 990, PART XII, LINE 2C:

“Organization oversight: the process for overseeing the audit of the financial statements and selection of an independent accountant that audited the financial statements has been consistent with prior years.”

Financial Statement Notes

PART X, LINE 2:

“Ipm is generally exempt from federal income taxes under the provisions of section 501(c)(3) of the internal revenue code (irc). In addition, ipm qualifies for charitable contributions deductions and has been classified as an organization that is not a private foundation. Income which is not related to exempt purposes, less applicable deductions, is subject to federal and state corporate income taxes. The organization recorded a tax liability for unrelated business income of $0 for the years ended december 31, 2021 and 2020. Generally, ipm is no longer subject to u.s. Federal or state tax examinations by tax authorities on its tax returns submitted prior to 2018. Ipm-belgium was formed in february 2017 as a legal non-profit organization and is generally exempt from corporate income taxes under article 220 itc92 of the belgian corporate law. Certain gains and income items may be subject to the moral person tax laws. Management reviewed these items and determined there was no tax liability for the years ended december 31, 2021 and 2020.”

PART XI, LINE 2D - OTHER ADJUSTMENTS:

“Foreign currency loss -69,396. Revenue of affiliates in consolidated financials 2,973,276.”

PART XII, LINE 2D - OTHER ADJUSTMENTS:

“Expenses of affiliates in consolidated financials 3,020,964.”

Raw XML AppendixShowing 400 of 803 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt03127333
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt02854197
IRS990/AccountsReceivableGrp/BOYAmt0115729
IRS990/AccountsReceivableGrp/EOYAmt0531162
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0TO DEVELOP HIV PREVENTION PRODUCTS AND OTHER SEXUAL AND REPRODUCTIVE HEALTH TECHNOLOGIES FOR WOMEN, AND TO MAKE THEM AVAILABLE AND ACCESSIBLE WHERE THEY ARE URGENTLY NEEDED.
IRS990/AllOtherContributionsAmt0622301
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt01930
IRS990/AllOtherExpensesGrp/TotalAmt01930
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd01
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0KATHLEEN FLYNN CFO
IRS990/BooksInCareOfDetail/PhoneNum03016082221
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt08405 COLESVILLE ROAD 600
IRS990/BooksInCareOfDetail/USAddress/CityNm0SILVER SPRING
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990/BooksInCareOfDetail/USAddress/ZIPCd020910
IRS990/BusinessRlnWith35CtrlEntInd00
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt015149778
IRS990/CashNonInterestBearingGrp/EOYAmt011255745
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt024
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt034730
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0867932
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt02178717
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt03081379
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt010818
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt015414
IRS990/ConferencesMeetingsGrp/TotalAmt026232
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/ContractorCompensationGrp/CompensationAmt03338990
IRS990/ContractorCompensationGrp/CompensationAmt12296963
IRS990/ContractorCompensationGrp/CompensationAmt2384905
IRS990/ContractorCompensationGrp/CompensationAmt3356337
IRS990/ContractorCompensationGrp/CompensationAmt4295771
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt0BOX 590 SE-201 25
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/AddressLine1Txt1COOPPALLAAN 90
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm0MALMO
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CityNm1WETTERN
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd0SW
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/CountryCd1BE
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd00
IRS990/ContractorCompensationGrp/ContractorAddress/ForeignAddress/ForeignPostalCd10
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt01050 CINDY LANE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt111921 ROCKVILLE PIKE STE 210
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/AddressLine1Txt2222 W LAS COLINAS BLVD STE 900N
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm0CARPINTERIA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm1ROCKVILLE
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/CityNm2ALLEN
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd0CA
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd1MD
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/StateAbbreviationCd2TX
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd093013
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd120852
IRS990/ContractorCompensationGrp/ContractorAddress/USAddress/ZIPCd275039
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt0QPHARMA AB
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt1AJINOMOTO OMNICHEM NV
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt2NUSIL TECHNOLOGY LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt3OSIBEYOND LLC
IRS990/ContractorCompensationGrp/ContractorName/BusinessName/BusinessNameLine1Txt4CELANESE CANADA ULC
IRS990/ContractorCompensationGrp/ServicesDesc0MANUFACTURING
IRS990/ContractorCompensationGrp/ServicesDesc1MANUFACTURING
IRS990/ContractorCompensationGrp/ServicesDesc2MANUFACTURING
IRS990/ContractorCompensationGrp/ServicesDesc3IT SERVICES
IRS990/ContractorCompensationGrp/ServicesDesc4CLINICAL TRIAL & REGULATORY SUP. FEE
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt020007666
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt023382
IRS990/CYOtherExpensesAmt011333754
IRS990/CYOtherRevenueAmt0189575
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt0319166
IRS990/CYSalariesCompEmpBnftPaidAmt08567703
IRS990/CYTotalExpensesAmt019901457
IRS990/CYTotalFundraisingExpenseAmt0229891
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt020220623
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt08268635
IRS990/DeferredRevenueGrp/EOYAmt01126246
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt0115443
IRS990/DepreciationDepletionGrp/ProgramServicesAmt0513021
IRS990/DepreciationDepletionGrp/TotalAmt0628464
IRS990/Desc0PRODUCT DEVELOPMENT: THE PRODUCT DEVELOPMENT (PD) DIVISION LEADS NON-CLINICAL, FORMULATION, MANUFACTURING, CHEMISTRY MANUFACTURING AND CONTROLS (CMC), ANALYTICAL, AND MATERIAL PLANNING AND SUPPLY ACTIVITIES FOR IPM'S PRODUCTS. THIS DIVISION IS RESPONSIBLE FOR PRODUCT SUPPLY AND ASSOCIATED ACTIVITIES (INCLUDING PRODUCT MANUFACTURING, PACKAGING, LABELING, DISTRIBUTION, AND STABILITY) AND THE POST-USE TESTING OF DAPIVIRINE RINGS TO SUPPORT ADHERENCE ASSESSMENTS DURING CLINICAL TRIALS. IN 2021, PD'S EFFORTS INCLUDED CONDUCTING CMC ACTIVITIES TO ADDRESS FEEDBACK RECEIVED FROM REGULATORY AGENCIES, INCLUDING THE QUESTIONS RECEIVED FROM THE EMA AS PART OF THE REVIEW PROCESS OF THE MONTHLY DAPIVIRINE RING REGULATORY DOSSIER AND AS A PART OF THE POST-AUTHORIZATION COMMITMENTS TO THE EMA. FOLLOWING THE POSITIVE SCIENTIFIC OPINION FROM THE EMA FOR THE DVR, THE PD TEAM CONTINUED EFFORTS RELATED TO COMMERCIAL MANUFACTURING OF THE DVR. THIS INCLUDED COMPLETING CAPACITY PLANNING WITH CRITICAL VENDORS SUCH AS IPM'S DVR PRODUCT MANUFACTURING PARTNER, IPM'S DAPIVIRINE DRUG SUBSTANCE MANUFACTURING PARTNERS, AND IPM'S SILICONE MANUFACTURING PARTNER. ADDITIONALLY, IPM SUPPORTED THE COMPLETION OF MANUFACTURING SCALE-UP (1X TO 5X) PROCESS VALIDATION. THE 5X PROCESS VALIDATION WAS COMPLETED IN 2022 AND WILL BE USED AS THE DVR MANUFACTURING SCALE GOING FORWARD. FURTHER, THE PD TEAM CONTINUED DEVELOPING THE THREE-MONTH DAPIVIRINE RING AND THE DAPIVIRINE-CONTRACEPTIVE RING.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DonorAdvisedFundInd00
IRS990/DonorRstrOrQuasiEndowmentsInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt035
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt010020993
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditPerformedInd01
IRS990/FederalGrantAuditRequiredInd01
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt0111596
IRS990/FeesForServicesAccountingGrp/TotalAmt0111596
IRS990/FeesForServicesLegalGrp/FundraisingAmt0446
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt043837
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt0243747
IRS990/FeesForServicesLegalGrp/TotalAmt0288030
IRS990/ForeignActivitiesInd00
IRS990/ForeignCountryCd0SF
IRS990/ForeignFinancialAccountInd01
IRS990/ForeignOfficeInd01
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt032.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt11.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt21.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt31.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt41.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt51.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt61.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt71.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt81.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt91.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt101.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt111.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1440.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1540.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1640.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1740.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1840.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1940.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt2040.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd2X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd3X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd10X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd11X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/KeyEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt048799
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt100
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt110
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1242719
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1314522
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1465006
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1562017
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1655660
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1752853
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1850449
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1959724
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt2053216
IRS990/Form990PartVIISectionAGrp/PersonNm0ZEDA ROSENBURG
IRS990/Form990PartVIISectionAGrp/PersonNm1PAMELA BARNES
IRS990/Form990PartVIISectionAGrp/PersonNm2GEORGINA CASWELL
IRS990/Form990PartVIISectionAGrp/PersonNm3ALEX COUTINHO
IRS990/Form990PartVIISectionAGrp/PersonNm4WILLIAM COLLIER
IRS990/Form990PartVIISectionAGrp/PersonNm5ANJA GIPHART
IRS990/Form990PartVIISectionAGrp/PersonNm6FLORENCE HOUN
IRS990/Form990PartVIISectionAGrp/PersonNm7HILDE FRAFJORD JOHNSON
IRS990/Form990PartVIISectionAGrp/PersonNm8MAUREEN LUBA
IRS990/Form990PartVIISectionAGrp/PersonNm9MARK MITCHNICK
IRS990/Form990PartVIISectionAGrp/PersonNm10TLALENG MOFOKENG
IRS990/Form990PartVIISectionAGrp/PersonNm11LILLIAN MWOREKO
IRS990/Form990PartVIISectionAGrp/PersonNm12KATHLEEN FLYNN
IRS990/Form990PartVIISectionAGrp/PersonNm13MICHAEL GOLDRICH
IRS990/Form990PartVIISectionAGrp/PersonNm14BRID DEVLIN
IRS990/Form990PartVIISectionAGrp/PersonNm15PATRICIA MAYER-BRENNAN
IRS990/Form990PartVIISectionAGrp/PersonNm16LIZA FOLSTEIN
IRS990/Form990PartVIISectionAGrp/PersonNm17JEREMY NUTTALL
IRS990/Form990PartVIISectionAGrp/PersonNm18ANITA GARG
IRS990/Form990PartVIISectionAGrp/PersonNm19PATRICK SPENCE
IRS990/Form990PartVIISectionAGrp/PersonNm20BINDI DANGI
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0517811
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12340789
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13129902
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt14406786
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt15389040
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt16270272
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt17271289
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt18259613
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt19237473
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20226865
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt140
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt150
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt160
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt170
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt180
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt190
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt200
IRS990/Form990PartVIISectionAGrp/TitleTxt0FOUNDER & CEO
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt11DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt12EVP, CHIEF FINANCIAL OFFICER
IRS990/Form990PartVIISectionAGrp/TitleTxt13PRESIDENT & COO -UNTIL 03/2021
IRS990/Form990PartVIISectionAGrp/TitleTxt14EVP, PRODUCT DEVELOPMENT
IRS990/Form990PartVIISectionAGrp/TitleTxt15EVP, REGULATORY AFFAIRS
IRS990/Form990PartVIISectionAGrp/TitleTxt16VP, HUMAN RESOURCES
IRS990/Form990PartVIISectionAGrp/TitleTxt17VP, PRECLINICAL SCIENCES
IRS990/Form990PartVIISectionAGrp/TitleTxt18VP, STRAT. PLANNING & PROG. MGMT.
IRS990/Form990PartVIISectionAGrp/TitleTxt19SR. DIR, CHEMISTRY & ANALYTICAL
IRS990/Form990PartVIISectionAGrp/TitleTxt20SR. DIR, PROJECT MGMT & OPS
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt012
IRS990/GovernmentGrantsAmt019385365
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossReceiptsAmt020220623
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt012
IRS990/IndivRcvdGreaterThan100KCnt041
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InsuranceGrp/ManagementAndGeneralAmt073528
IRS990/InsuranceGrp/ProgramServicesAmt0184784
IRS990/InsuranceGrp/TotalAmt0258312
IRS990/InventoriesForSaleOrUseGrp/BOYAmt0458683
IRS990/InventoriesForSaleOrUseGrp/EOYAmt0721130
IRS990/InvestmentIncomeGrp/ExclusionAmt023382
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt023382
IRS990/InvestmentInJointVentureInd00
IRS990/IRPDocumentCnt028
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt06059803
IRS990/LandBldgEquipBasisNetGrp/BOYAmt01600635
IRS990/LandBldgEquipBasisNetGrp/EOYAmt0923074
IRS990/LandBldgEquipCostOrOtherBssAmt06982877
IRS990/LegalDomicileStateCd0NC
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0TO DEVELOP HIV PREVENTION PRODUCTS AND OTHER SEXUAL AND REPRODUCTIVE HEALTH TECHNOLOGIES FOR WOMEN, AND TO MAKE THEM AVAILABLE AND ACCESSIBLE WHERE THEY ARE URGENTLY NEEDED.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt011554369
IRS990/NetAssetsOrFundBalancesEOYAmt011828967
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NoDonorRestrictionNetAssetsGrp/BOYAmt011554369
IRS990/NoDonorRestrictionNetAssetsGrp/EOYAmt011828967
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt021736
IRS990/OccupancyGrp/ProgramServicesAmt0237052
IRS990/OccupancyGrp/TotalAmt0258788
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt089728
IRS990/OfficeExpensesGrp/ProgramServicesAmt01319343
IRS990/OfficeExpensesGrp/TotalAmt01409071
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsFASB117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-69396
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt010450
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt0233798
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt0469508
IRS990/OtherEmployeeBenefitsGrp/TotalAmt0713756
IRS990/OtherExpensesGrp/Desc0CONTRACTED PROGRAM SERV
IRS990/OtherExpensesGrp/Desc1CONTRACT PERSONNEL
IRS990/OtherExpensesGrp/Desc2COMMUNICATIONS
IRS990/OtherExpensesGrp/Desc3OTHER EXPENSES
IRS990/OtherExpensesGrp/FundraisingAmt0108783
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt0397178
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt133063
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt241132
IRS990/OtherExpensesGrp/ProgramServicesAmt05770753
IRS990/OtherExpensesGrp/ProgramServicesAmt11917440
IRS990/OtherExpensesGrp/ProgramServicesAmt277427
IRS990/OtherExpensesGrp/ProgramServicesAmt33578
IRS990/OtherExpensesGrp/TotalAmt05770753
IRS990/OtherExpensesGrp/TotalAmt12423401
IRS990/OtherExpensesGrp/TotalAmt2110490
IRS990/OtherExpensesGrp/TotalAmt344710
IRS990/OtherLiabilitiesGrp/BOYAmt0520356
IRS990/OtherLiabilitiesGrp/EOYAmt0404669
IRS990/OtherRevenueMiscGrp/Desc0MISCELLANEOUS INCOME
IRS990/OtherRevenueMiscGrp/ExclusionAmt0189575
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt0189575
IRS990/OtherRevenueTotalAmt0189575
IRS990/OtherSalariesAndWagesGrp/FundraisingAmt060260
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt01257613
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt02429350
IRS990/OtherSalariesAndWagesGrp/TotalAmt03747223
IRS990/PartialLiquidationInd00
IRS990/PayrollTaxesGrp/FundraisingAmt06278
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt0126611
IRS990/PayrollTaxesGrp/ProgramServicesAmt0291033
IRS990/PayrollTaxesGrp/TotalAmt0423922
IRS990/PensionPlanContributionsGrp/FundraisingAmt08944
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt0191468
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt0401011
IRS990/PensionPlanContributionsGrp/TotalAmt0601423
IRS990/PledgesAndGrantsReceivableGrp/BOYAmt05388424
IRS990/PledgesAndGrantsReceivableGrp/EOYAmt01906142
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0464624
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0513564
IRS990/PrincipalOfficerNm0KATHLEEN FLYNN
IRS990/PriorPeriodAdjustmentsAmt024828
IRS990/ProfessionalFundraisingInd00
IRS990/ProgSrvcAccomActy2Grp/Desc0REGULATORY AFFAIRS AND QUALITY ASSURANCE: IPM'S REGULATORY AFFAIRS TEAM OVERSEES THE MONTHLY DAPIVIRINE RING REGULATORY PROCESS, PROVIDING LEADERSHIP IN DOSSIER PREPARATION, FILINGS, AND POST-APPROVAL MAINTENANCE IN EUROPE, THE UNITED STATES, SOUTH AFRICA, AND OTHER TARGET AFRICAN COUNTRIES, WHERE IPM IS PREPARING FOR THE MARKET INTRODUCTION OF THE RING. THIS DIVISION ALSO SUPPORTS ALL REGULATORY EFFORTS FOR OTHER IPM PRODUCTS ON THE PRODUCT DEVELOPMENT PATHWAY; THIS SUPPORT INCLUDES SUBMISSION AND MAINTENANCE OF INVESTIGATIONAL NEW DRUG (IND) DOCUMENTATION AND CONDUCTING REGULATORY AGENCY INTERACTIONS RELATED TO NEW PROTOCOLS FOR UPCOMING CLINICAL TRIALS. IMPORTANTLY, IN 2021, THE REGULATORY AFFAIRS TEAM MANAGED ALL POST-AUTHORIZATION MEASURES RELATED TO THE EMA'S POSITIVE SCIENTIFIC OPINION OF THE MONTHLY DVR. ADDITIONALLY, THE TEAM COMPLETED THE NECESSARY ACTIVITIES TO SECURE WORLD HEALTH ORGANIZATION (WHO) PREQUALIFICATION (PQ) AND A RECOMMENDATION FROM THE WHO AS AN ADDITIONAL HIV PREVENTION CHOICE FOR WOMEN AS PART OF COMBINATION PREVENTION. THE MONTHLY DVR IS NOW UNDER REGULATORY REVIEW IN AFRICAN COUNTRIES. THESE EFFORTS WERE THEN LEVERAGED, AND THE DVR DOSSIER WAS SUBMITTED TO NUMEROUS AFRICAN COUNTRIES FOR REVIEW AND APPROVAL. BY THE END OF 2021, THE MONTHLY DVR HAD RECEIVED APPROVAL FROM 5 AFRICAN COUNTRIES. THE MONTHLY DVR REMAINS UNDER REGULATORY REVIEW IN ADDITIONAL AFRICAN COUNTRIES.IN PARTNERSHIP WITH THE REGULATORY AFFAIRS TEAM, THE QUALITY ASSURANCE (QA) TEAM ENSURES IPM'S PRODUCT DEVELOPMENT AND CLINICAL STUDIES ARE CONDUCTED IN COMPLIANCE WITH ALL APPLICABLE DRUG AND SAFETY LAWS. AUDITS ARE CONDUCTED DURING CLINICAL TRIALS TO ASSURE PROTOCOL COMPLIANCE AND COMPLIANCE WITH AN INTERNATIONAL CONFERENCE ON HARMONIZATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH) GUIDELINES, GOOD CLINICAL PRACTICES (GCP), AND ALL APPLICABLE REGULATIONS. VENDOR AUDITS ARE ALSO CONDUCTED WHERE IPM'S CLINICAL, PRECLINICAL, OR CMC WORK IS CONDUCTED.
IRS990/ProgSrvcAccomActy2Grp/ExpenseAmt03293544
IRS990/ProgSrvcAccomActy3Grp/Desc0CLINICAL AND MEDICAL AFFAIRS: IPM'S CLINICAL AFFAIRS DEPARTMENT IS RESPONSIBLE FOR QUALITY CONTROL AND COMPLIANCE, MEDICAL SAFETY, PHARMACOVIGILANCE, MEDICAL AFFAIRS, CLINICAL OPERATIONS, BIOMETRICS, PUBLIC AFFAIRS, COMMUNITY PUBLIC AFFAIRS, AND SOCIO-BEHAVIORAL SCIENCES FOR THE CLINICAL TRIALS CONDUCTED ON IPM'S PRODUCTS. KEY ACTIVITIES IN 2021 INCLUDED:- CONTINUED SUPPORT OF THE MONTHLY DAPIVIRINE VAGINAL RING (DVR) CLINICAL TRIALSIPM WORKED WITH ITS CLINICAL TRIAL PARTNER, THE UNITED STATES (US) NATIONAL INSTITUTES OF HEALTH (NIH)-FUNDED MICROBICIDE TRIALS NETWORK (MTN) ON THE SUBSEQUENT CLINICAL TRIALS OF THE DVR:O MTN-034 (REACH): A PHASE 2A CROSSOVER TRIAL EVALUATING THE SAFETY OF AND ADHERENCE TO A VAGINAL MATRIX RING CONTAINING DAPIVIRINE AND ORAL EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE IN AN ADOLESCENT AND YOUNG ADULT FEMALE POPULATIONO MTN-042 (DELIVER): PHASE 3B, RANDOMIZED, OPEN-LABEL SAFETY TRIAL OF DAPIVIRINE VAGINAL RING (VR) AND ORAL TRUVADA USE IN PREGNANCYO MTN-043 (B-PROTECTED): PHASE 3B, OPEN-LABEL, SAFETY AND DRUG DETECTION STUDY OF DAPIVIRINE VAGINAL RING AND ORAL TRUVADA IN BREASTFEEDING MOTHER-INFANT PAIRSFURTHER, THE CLINICAL AND MEDICAL AFFAIRS TEAM SUPPORTED THE REGULATORY AFFAIRS TEAM IN DEVELOPING AND COMPLETING THE CLINICAL MODULES AND POST-APPROVAL AMENDMENTS OF THE DVR DOSSIERS SUBMITTED TO REGULATORY AUTHORITIES. - CLINICAL TRIAL OF IPM'S THREE-MONTH DAPIVIRINE RING BUILDING ON THE PROMISE OF IPM'S MONTHLY DAPIVIRINE RING, IPM DEVELOPED THE THREE-MONTH DAPIVIRINE RING, DESIGNED TO INCREASE CONVENIENCE AND REDUCE ANNUAL COSTS COMPARED TO THE MONTHLY DAPIVIRINE RING. THE CLINICAL AFFAIRS TEAM WORKED ACROSS DEPARTMENTS AND WITH EXTERNAL PARTNERS TO DEVELOP THE PROTOCOL FOR THE BRIDGING TRIAL AND COMPLETE ALL NECESSARY TRIAL PREPARATIONS. THE BRIDGING TRIAL (IPM 054) WAS INITIATED IN Q3 2022.- CLINICAL TRIALS OF THE DAPIVIRINE-CONTRACEPTIVE VAGINAL RING, A MULTIPURPOSE PREVENTION TECHNOLOGY (MPT)THE THREE-MONTH DAPIVIRINE-CONTRACEPTIVE RING IS DESIGNED TO PROVIDE SLOW AND SIMULTANEOUS RELEASE OF THE ANTIRETROVIRAL (ARV) DRUG DAPIVIRINE TO PREVENT HIV AND THE CONTRACEPTIVE HORMONE LEVONORGESTREL TO PREVENT UNINTENDED PREGNANCY. A SECOND PHASE I CLINICAL TRIAL OF THE REFORMULATED MPT RING (IPM 056/CCTN019B) WAS IN THE PLANNING STAGES THROUGHOUT 2021 AND INITIATED IN MID-2022. THIS TRIAL WILL BE CONDUCTED BY THE EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT (NICHD).
IRS990/ProgSrvcAccomActy3Grp/ExpenseAmt0953165
IRS990/ProgSrvcAccomActyOtherGrp/Desc0PROGRAM SUPPORT & ACCESS: IN 2021, IPM CONTINUED TO BUILD AWARENESS GLOBALLY ABOUT MICROBICIDES AND CREATE A FAVORABLE ENVIRONMENT SUPPORTING MICROBICIDE PRODUCT DEVELOPMENT AND INTRODUCTION. THIS IS ACHIEVED BY INFORMING, EDUCATING, AND BUILDING SUPPORT FOR IPM'S WORK THROUGH COMMUNICATION MATERIALS, ADVOCACY, AND DIRECT STAKEHOLDER ENGAGEMENT. IN CONJUNCTION WITH THESE EFFORTS, IPM ALSO CONTINUED WORK TO ENSURE THAT THE DVR CAN QUICKLY REACH WOMEN IN DEVELOPING COUNTRIES WHO FACE THE HIGHEST RISK OF HIV. THIS WORK INCLUDES PARTNERING WITH A GLOBAL NETWORK OF ORGANIZATIONS, INCLUDING GOVERNMENT, PHARMACEUTICAL, HEALTH SERVICES, CIVIL SOCIETY, AND ACADEMIC SECTORS, TO STRATEGICALLY PLAN FOR AFFORDABLE ACCESS TO THE DAPIVIRINE RING.
IRS990/ProgSrvcAccomActyOtherGrp/ExpenseAmt01786453
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt020127462
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt037322
IRS990/PYOtherExpensesAmt010543513
IRS990/PYOtherRevenueAmt00
IRS990/PYProgramServiceRevenueAmt00
IRS990/PYRevenuesLessExpensesAmt0-587370

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2021 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$16,214,079
Liabilities
$4,385,112
Net assets
$11,828,967
Revenue
$20,220,623
Expenses
$19,901,457
Net income
$319,166
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.00$0.00$0.00$9.96$12.8$2.84
2021Detailed filing. Detailed filing data is available for this year.$16.2$4.39$11.8$20.2$19.9$0.32
2020Detailed filing. Detailed filing data is available for this year.$23.5$11.9$11.6$20.2$20.8$0.59
2019Facts available. Structured filing facts are available, but richer extracted sections are limited.$28.1$15.7$12.4$25.2$24.8$0.48
2018Facts available. Structured filing facts are available, but richer extracted sections are limited.$24.8$12.8$12.0$25.2$26.3$1.13
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$23.0$9.79$13.3$35.7$36.8$1.08
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$20.1$5.53$14.5$36.0$33.8$2.19
2015Import issue. A filing source exists for this year, but detailed import did not complete cleanly.$23.2$10.2$13.0$33.0$33.2$0.22
2014Detailed filing. Detailed filing data is available for this year.$28.9$14.1$14.8$31.6$32.2$0.69
2013Detailed filing. Detailed filing data is available for this year.$40.5$23.4$17.1$32.8$33.4$0.66
2012Summary only. Only limited summary data is available for this year.$42.0$22.7$19.3$31.7$31.0$0.64
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$52.6$31.5$21.1$37.7
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$81.5$58.2$23.3$56.3